Dover Work in process increased by 9.5% to $258.02M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.1%, from $250.14M to $258.02M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 9.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $206.29M | $232.26M | $271.66M | $291.60M | $308.71M | $311.82M | $230.87M | $254.14M | $260.24M | $231.99M | $214.93M | $242.42M | $241.64M | $254.57M | $233.54M | $250.14M | $260.81M | $246.99M | $235.52M | $258.02M |
| QoQ Change | — | +12.6% | +17.0% | +7.3% | +5.9% | +1.0% | -26.0% | +10.1% | +2.4% | -10.9% | -7.4% | +12.8% | -0.3% | +5.4% | -8.3% | +7.1% | +4.3% | -5.3% | -4.6% | +9.5% |
| YoY Change | — | — | — | — | +49.6% | +34.3% | -15.0% | -12.8% | -15.7% | -25.6% | -6.9% | -4.6% | -7.1% | +9.7% | +8.7% | +3.2% | +7.9% | -3.0% | +0.8% | +3.1% |
| % of Inventories | 18.6% | 19.5% | 20.6% | 20.0% | 20.4% | 20.3% | 15.4% | 16.4% | 16.9% | 16.4% | 17.1% | 17.7% | 17.6% | 18.9% | 18.3% | 18.7% | 18.1% | 16.8% | 16.5% | 17.0% |
| Share Change | — | +0.9pp | +1.0pp | -0.5pp | +0.4pp | -0.1pp | -4.9pp | +1.1pp | +0.5pp | -0.5pp | +0.6pp | +0.6pp | -0.0pp | +1.3pp | -0.6pp | +0.3pp | -0.6pp | -1.2pp | -0.3pp | +0.4pp |